Identifying biomarkers of differential chemotherapy response in TNBC patient-derived xenografts with a CTD/WGCNA approach
2022 · iScience · 31 citations
https://doi.org/10.1016/j.isci.2022.105799
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
56
Papers
91
Citations
5
h-index
4
i10-index
Christina Sallas is an academic researcher from Baylor College of Medicine. The author has contributed to research in topics: HER2/EGFR in Cancer Research & Advanced Breast Cancer Therapies & Lung Cancer Treatments and Mutations. The author has an h-index of 5, co-authored 48 publications.
ORCID: 0009-0005-2194-0522https://doi.org/10.1016/j.isci.2022.105799
https://doi.org/10.1016/j.xcrm.2023.101326
https://doi.org/10.1016/j.xcrm.2024.101834
Click to start Chat